Back Back
Cell No. : Cell Name
RCB0450 : Anr9-1  update : 2022/03/15
CommentEJ-ras oncogene transformed ARLJ301-3
Comment from the depositor
Terms and conditionsThere is no restriction regarding use for basic researches. In relation to commercial use and use for patent filing, first of all please contact the RIKEN BRC.
Order Form Order Form(C-0005.pdf)   MTA(C-0007.pdf)   MTA(C-0007p.pdf)  
Regarding MTA between user institutions and RIKEN BRC, there are two kinds of MTA, not-for-profit academic purpose (C-XXXX) and for-profit research purpose (C-XXXXp) , depending on the sort of user institutions and the purposes of use. Please use an appropriate MTA(to see). In relation to commercial use and use for patent filing, first of all Please contact RIKEN BRC (
Basic information Depositor Furukawa, Kazunori
Originator Sato, S.
Year of deposit 1989
Original cell ARLJ301-3
Animal _rat < Mammals
Strain name F344/DuCrj
Gender Male
Age at sampling 10 weeks
Tissue liver
Classification transformed
Recombinant recombinant
Exogene EJ-ras
Year of origin 1989
Lifespan infinite
Morphology fibroblast-like
Cellosaurus(Expasy) CVCL_4576
deposit info
lot info
Medium Medium List
Culture type Adherent cells
Culture medium William's E + 10% FBS (heat inactivated)
Antibiotics Free
Passage method 0.25% Trypsin
Culture information Passage ratio 1 : 8 split
SC frequency Subculture : 2 times/week
Temperature 37 ℃
CO2 concentration 5 %
Freeze medium Medium + 10% DMSO
Freezing method Slow freezing
Mycoplasma (-)
Animal PCR OK
Isozyme LD, NP
deposit info
lot info
Reference information Reference 0
User's Publication 1

To topTop

To topTop
User's Publication
17949  Kageyama Y, Yamazaki Y, Afify AS, Ogawa Y, Okada T, Okuno H.  Stereoselective hydrolysis of xenobiotic esters by different cell lines from rat liver and hepatoma and its application to chiral prodrugs for designated growth suppression of cancer cells  Chirality  1995  7(4):297-304  PubMed ID: 7640174   DOI: 10.1002/chir.530070418

Back Back Return Top Page